Hong Kong – Lippo China Resources Limited reported full-year 2025 revenue of HK$864.46 million, an 11.5% increase from 2024, driven mainly by a 13.0% rise in food-business turnover to HK$821.23 million.
The Group’s consolidated net loss narrowed to HK$55.57 million from HK$708.76 million a year earlier. Loss attributable to shareholders declined to HK$61.27 million (2024: HK$683.70 million), translating into a basic loss per share of HK$0.07 versus HK$0.74 in 2024. The improvement chiefly reflected:
• Absence of the HK$386.48 million litigation settlement booked in 2024. • A swing to a HK$4.14 million net fair-value gain on financial instruments (2024: HK$63.30 million loss). • A HK$41.01 million reduction in other operating expenses, notably lower legal and professional fees. • A HK$97.89 million tax credit, largely due to the reversal of prior-year over-provisions.
Segment performance • Food businesses posted a HK$16.06 million profit, reversing a HK$34.76 million loss in 2024. Revenue was fuelled by stronger bakery sales in Singapore and Malaysia, where Malaysian contribution rose to 24% of segment sales. • Property investment recorded a HK$59.84 million loss, narrowing from HK$118.32 million, despite a HK$20.92 million fair-value drop in investment properties and a HK$40.54 million impairment on owner-occupied buildings. • Treasury and securities investments showed a HK$27.23 million loss, versus HK$57.83 million in 2024, aided by a HK$6.78 million fair-value gain on listed holdings offset by a HK$40.67 million impairment on a joint venture. • Share of profit from associates totalled HK$23.44 million (2024: HK$41.80 million), led by TIH Limited’s HK$20.00 million contribution and Healthway Medical’s HK$3.44 million profit.
Balance-sheet highlights Total assets stood at HK$3.46 billion (2024: HK$3.50 billion). Net assets edged up to HK$2.10 billion, or HK$2.03 per share. Cash and cash equivalents were HK$233.88 million, while bank and other borrowings totalled HK$952.09 million; the gearing ratio (net borrowings to shareholders’ equity) improved to 48.1% from 53.0%.
Capital management & commitments A HK$1.56 billion capital reduction became effective on 29 July 2025, lowering issued share capital to HK$150.00 million and partially offsetting accumulated losses. Capital commitments rose to HK$159.76 million, mainly for new commercial food-manufacturing equipment.
Dividend The Board resolved not to declare a final dividend for 2025; no interim dividend was paid during the year.
Post-balance-sheet event In February 2026, the Group recovered US$24.75 million (approximately HK$192.62 million) from insurers in relation to the 2024 litigation settlement; this sum will be recognised in 2026 results.
Outlook Management expects cautious economic recovery in key markets but notes persistent macro-economic and geopolitical uncertainties. The Group will maintain prudent capital management while focusing on its core food, property and investment operations.